Developing standardized tumor biomarking
The complexity of cancer biology often makes cancer treatment very difficult. Having a standardized approach to mapping tumor biomarkers is essential to cancer research and our understanding of treatment effectiveness.
Tumor biomarkers are very useful to help detect, diagnose and manage cancers. For some cancers, biomarkers can help identify patients most likely to respond to targeted therapies or treatments. But what is a successful approach to standardized biomarking?
This white paper dives into the oncology data enhancement initiative Optum developed to standardize mapping of oncology biomarkers. Learn how Optum uses its vast data and a two-part strategy for research and investigation.